C19orf47 antibody
Principal name
C19orf47 antibody
Alternative names for C19orf47 antibody
Uncharacterized protein C19orf47
Ncbi ID
NP_849152, NP_849152.1, NP_001116239.1, NM_175107, NM_001122767
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of C19orf47 antibody
- Kit Component:
- - KN300234G1, 2310022A10Rik gRNA vector 1 in pCas-Guide vector
- KN300234G2, 2310022A10Rik gRNA vector 2 in pCas-Guide vector
- KN300234D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Mehrle,A., Nucleic Acids Res. 34 (DATABASE ISSUE), D415-D418 (2006)
Human Jurkat; WB Suggested Anti-C19orf47 Antibody Titration: 0.2-1 ug/ml. Positive Control: Jurkat cell lysate; C19orf47 antibody - C-terminal region (ARP48453_P050) in Human Jurkat cells using Western Blot
Human Muscle; WB Suggested Anti-C19orf47 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Human Muscle; C19orf47 antibody - middle region (ARP48452_P050) in Human Muscle cells using Western Blot
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR206523L2V | Lenti ORF particles, 2310022A10Rik (GFP-tagged) - Mouse RIKEN cDNA 2310022A10 gene (2310022A10Rik), transcript variant 1, 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR212574L2V | Lenti ORF particles, 2310022A10Rik (GFP-tagged) - Mouse RIKEN cDNA 2310022A10 gene (2310022A10Rik), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR206523L1V | Lenti ORF particles, 2310022A10Rik (Myc-DDK-tagged) - Mouse RIKEN cDNA 2310022A10 gene (2310022A10Rik), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
| MR212574L1V | Lenti ORF particles, 2310022A10Rik (Myc-DDK-tagged) - Mouse RIKEN cDNA 2310022A10 gene (2310022A10Rik), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||